相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term Use of Inhaled Corticosteroids in COPD and the Risk of Fracture
Anne V. Gonzalez et al.
CHEST (2018)
Indacaterol/glycopyrronium: a dual bronchodilator for COPD
Donald Banerji et al.
DRUG DISCOVERY TODAY (2018)
Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
Anthony D. D'Urzo et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Optimal Bronchodilation for COPD Patients: Are All Long-Acting beta(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?
Marc Miravitlles et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2018)
Assessing Short-term Deterioration in Maintenance naive Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials
M. Reza Maleki-Yazdi et al.
ADVANCES IN THERAPY (2017)
The risk of mycobacterial infections associated with inhaled corticosteroid use
Sarah K. Brode et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events
Samy Suissa et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
When is dual bronchodilation indicated in COPD?
Mike Thomas et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
Gustavo J. Rodrigo et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD
Jadwiga A. Wedzicha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: Pooled analysis of SHINE and ARISE
Kazuhisa Asai et al.
RESPIRATORY INVESTIGATION (2016)
Effects of tiotropium plus olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
Dave Singh et al.
RESPIRATORY RESEARCH (2016)
Efficacy of Tiotropium plus Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis
Gary T. Ferguson et al.
ADVANCES IN THERAPY (2015)
Survey to determine the efficacy and safety of guideline-based pharmacological therapy for chronic obstructive pulmonary disease patients not previously receiving maintenance treatment
Yasuhiro Setoguchi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients
Jadwiga A. Wedzicha et al.
RESPIRATORY MEDICINE (2014)
Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
David Price et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2014)
Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial
Thierry y Troosters et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2014)
Treadmill Endurance During 2-Year Treatment With Tiotropium in Patients With COPD A Randomized Trial
Christopher B. Cooper et al.
CHEST (2013)
Dual bronchodilation with QVA149 versus single bronchoditator therapy: the SHINE study
Eric D. Bateman et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Tiotropium Respimat Inhaler and the Risk of Death in COPD
Robert A. Wise et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
Jadwiga A. Wedzicha et al.
LANCET RESPIRATORY MEDICINE (2013)
Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study
Edward Kerwin et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial
Kai M. Beeh et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2012)
Lung function decline in COPD
Claudio Tantucci et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2012)
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Claus Vogelmeier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Tiotropium for Treatment of Stable COPD: A Meta-analysis of Clinically Relevant Outcomes
Abebaw Mengistu Yohannes et al.
RESPIRATORY CARE (2011)
Disease severity and symptoms among patients receiving monotherapy for COPD
Mark T. Dransfield et al.
PRIMARY CARE RESPIRATORY JOURNAL (2011)
Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
Anthony D'Urzo et al.
RESPIRATORY RESEARCH (2011)
Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
Samy Suissa et al.
AMERICAN JOURNAL OF MEDICINE (2010)
A one-year trial of tiotropium Respimat® plus usual therapy in COPD patients
E. D. Bateman et al.
RESPIRATORY MEDICINE (2010)
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Airway obstruction is common but unsuspected in patients admitted to a general medicine service
D Zaas et al.
CHEST (2004)
Underdiagnosis and undertreatment of COPD in primary care settings
TU Takahashi et al.
RESPIROLOGY (2003)
分享论文
